More on AUPH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $16.08 |
|
|||
| Open | $15.98 | ||||
| 52 Wk High | $5.69 | ||||
| 52 Wk Low | $1.42 | ||||
| Day High | $16.38 | ||||
| Day Low | $15.93 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 970,278 | ||||
- Form SCHEDULE 13D/A Aurinia Pharmaceuticals Filed by: ILJIN SNT Co., Ltd.
- Form 4 Aurinia Pharmaceuticals For: Aug 21 Filed by: Robertson Stephen P.
- Form 8-K Aurinia Pharmaceuticals For: Aug 19
- Form 144 Aurinia Pharmaceuticals Filed by: Robertson Stephen P.
- Bloom Burton & Co. Upgrades Aurinia Pharmaceuticals (AUPH) to Buy (1)
- Form 8-K Aurinia Pharmaceuticals For: Aug 19
- Aurinia settles patent dispute with Teva over generic voclosporin
- Aurinia Settles Patent Litigation with Teva
- Aurinia Pharmaceuticals (AUPH) PT Raised to $16 at RBC Capital
- Aurinia Pharmaceuticals (AUPH) Tops Q2 EPS by 5c
Entities mentioned with AUPH
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Jefferies & Co | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
